Mutational Processes Molding the Genomes of 21 Breast Cancers
暂无分享,去创建一个
A. Børresen-Dale | M. Stratton | P. Futreal | P. Campbell | P. Stephens | L. Stebbings | Catherine Leroy | J. Teague | A. Menzies | G. Bignell | M. Neuberger | J. Martens | P. Tarpey | P. Loo | C. Greenman | D. Wedge | S. Nik-Zainal | Sancha Martin | I. Varela | E. Papaemmanuil | A. Butler | J. Gamble | Jonathan Hinton | David Jones | K. Lau | S. McLaren | D. McBride | L. Mudie | K. Raine | A. Langerød | Aquila Fatima | P. Miron | G. Thomas | S. Boyault | A. Tutt | S. Aparicio | A. Salomon | A. Richardson | P. Van Loo | H. Davies | J. Marshall | L. Alexandrov | Å. Borg | Manasa Ramakrishna | Lina Chen | M. Maddison | R. Rance | J. Garber | G. Jönsson | A. Shlien | Kenric Leung | S. Cooke | I. Whitmore | D. Silver | John Gamble | Stuart McLaren | Richard Rance | Stuart Mclaren | G. Thomas | D. Mcbride
[1] AC Tose. Cell , 1993, Cell.
[2] C. Burant,et al. Molecular cloning of an apolipoprotein B messenger RNA editing protein. , 1993, Science.
[3] J. Taylor,et al. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[4] C. Harris,et al. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. , 1997, Carcinogenesis.
[5] H. Sebastian Seung,et al. Learning the parts of objects by non-negative matrix factorization , 1999, Nature.
[6] T. Waters,et al. Thymine-DNA glycosylase and G to A transition mutations at CpG sites. , 2000, Mutation research.
[7] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[8] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[9] E. Dougherty,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[10] P. Hainaut,et al. Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. , 2001, Carcinogenesis.
[11] M. Malim,et al. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein , 2002, Nature.
[12] N. Tretyakova,et al. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers , 2002, Oncogene.
[13] Reuben S Harris,et al. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. , 2002, Molecular cell.
[14] M. Goodman,et al. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation , 2003, Nature.
[15] Pablo Tamayo,et al. Metagenes and molecular pattern discovery using matrix factorization , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[16] G. Pfeifer,et al. Mutations induced by ultraviolet light. , 2005, Mutation research.
[17] Andrew D. Yates,et al. A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer , 2005, Nature Genetics.
[18] N. de Wind,et al. Strand-biased defect in C/G transversions in hypermutating immunoglobulin genes in Rev1-deficient mice , 2006, The Journal of experimental medicine.
[19] AID in somatic hypermutation and class switch recombination. , 2006, Current opinion in immunology.
[20] J. Sale,et al. The catalytic activity of REV1 is employed during immunoglobulin gene diversification in DT40. , 2006, Molecular immunology.
[21] V. Bohr,et al. The mechanics of base excision repair, and its relationship to aging and disease. , 2007, DNA repair.
[22] Michael W. Berry,et al. Algorithms and applications for approximate nonnegative matrix factorization , 2007, Comput. Stat. Data Anal..
[23] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[24] S. Sommer,et al. Evidence for mutation showers , 2007, Proceedings of the National Academy of Sciences.
[25] E. Birney,et al. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. , 2008, Genome research.
[26] J. Benítez,et al. The Molecular Pathology of Hereditary Breast Cancer , 2008, Pathobiology.
[27] Antony V. Cox,et al. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing , 2008, Nature Genetics.
[28] P. Hanawalt,et al. Transcription-coupled DNA repair: two decades of progress and surprises , 2008, Nature Reviews Molecular Cell Biology.
[29] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[30] Amy E. Hawkins,et al. DNA sequencing of a cytogenetically normal acute myeloid leukemia genome , 2008, Nature.
[31] A. Børresen-Dale,et al. COMPLEX LANDSCAPES OF SOMATIC REARRANGEMENT IN HUMAN BREAST CANCER GENOMES , 2009, Nature.
[32] Ken Chen,et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. , 2009, The New England journal of medicine.
[33] A. Ashworth,et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. , 2009, The New England journal of medicine.
[34] M. Stratton,et al. The cancer genome , 2009, Nature.
[35] Ryan D. Morin,et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.
[36] Z. Ning,et al. Amplification-free Illumina sequencing-library preparation facilitates improved mapping and assembly of GC-biased genomes , 2009, Nature Methods.
[37] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[38] M. Hollstein,et al. TP53 mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy‐associated tumours , 2009, International journal of cancer.
[39] Kai Ye,et al. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads , 2009, Bioinform..
[40] A. Sparks,et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient , 2010, Nature.
[41] M. Nussenzweig,et al. Origin of Chromosomal Translocations in Lymphoid Cancer , 2010, Cell.
[42] P. Deloukas,et al. Signatures of mutation and selection in the cancer genome , 2010, Nature.
[43] J. Haber,et al. Increased Mutagenesis and Unique Mutation Signature Associated with Mitotic Gene Conversion , 2010, Science.
[44] E. Birney,et al. A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.
[45] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[46] Joshua F. McMichael,et al. Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft , 2010, Nature.
[47] Tom Royce,et al. A comprehensive catalogue of somatic mutations from a human cancer genome , 2010, Nature.
[48] C. Perou,et al. Allele-specific copy number analysis of tumors , 2010, Proceedings of the National Academy of Sciences.
[49] M. Stenglein,et al. APOBEC3 proteins mediate the clearance of foreign DNA from human cells , 2010, Nature Structural &Molecular Biology.
[50] A. Malkova,et al. Break-Induced Replication Is Highly Inaccurate , 2011, PLoS biology.
[51] Trevor J Pugh,et al. Initial genome sequencing and analysis of multiple myeloma , 2011, Nature.
[52] M. Weitzman,et al. APOBEC3A can activate the DNA damage response and cause cell‐cycle arrest , 2011, EMBO reports.
[53] M. Stratton. Exploring the Genomes of Cancer Cells: Progress and Promise , 2011, Science.
[54] Lela Lackey,et al. Human and Rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H Demonstrate a Conserved Capacity To Restrict Vif-Deficient HIV-1 , 2011, Journal of Virology.
[55] A. Ashworth,et al. Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer , 2011, Nature Reviews Clinical Oncology.
[56] P. Pineau,et al. Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism , 2011, Proceedings of the National Academy of Sciences.
[57] Christopher D. Brown,et al. Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data , 2011, Proceedings of the National Academy of Sciences.
[58] N. Carter,et al. Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.
[59] Eric S. Lander,et al. The genomic complexity of primary human prostate cancer , 2010, Nature.
[60] N. Minakawa,et al. Mutagenicity of secondary oxidation products of 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate (8-hydroxy-2'- deoxyguanosine 5'-triphosphate). , 2011, Mutation research.
[61] A. Børresen-Dale,et al. The landscape of cancer genes and mutational processes in breast cancer , 2012, Nature.
[62] A. Børresen-Dale,et al. The Life History of 21 Breast Cancers , 2012, Cell.
[63] D. Cooper,et al. Transient hypermutability, chromothripsis and replication-based mechanisms in the generation of concurrent clustered mutations. , 2012, Mutation research.
[64] Oxidative DNA damage following microsome/Cu(II)-mediated activation of the estrogens, 17β-estradiol, equilenin, and equilin: role of reactive oxygen species. , 2012, Chemical research in toxicology.